Secular Trends in Central Nervous System-Active Polypharmacy Among Serial Cross-Sections of US Adults, 2009-2020.

Author: BurkeJames F, GerlachLauren B, GrowdonMatthew E, NiznikJoshua D, TermanSamuel W

Paper Details 
Original Abstract of the Article :
BACKGROUND: Data comprehensively examining trends in central nervous system (CNS)-active polypharmacy are limited. The objective of this cross-sectional study was to characterize the composition of and trends in CNS-active medication use in US adults. METHODS: We included all participants ≥ 18 year...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://pubmed.ncbi.nlm.nih.gov/37695395

データ提供:米国国立医学図書館(NLM)

The Growing Trend of CNS-Active Polypharmacy in US Adults

Our brains, the command centers of our bodies, are complex and intricate. Central Nervous System (CNS)-active medications are often prescribed to address a wide range of neurological and psychiatric conditions. Polypharmacy, the use of multiple medications, can be a double-edged sword. This study examines the prevalence of CNS-active polypharmacy in US adults and explores the trends in medication use from 2009 to 2020, focusing on the potential consequences of this growing trend.

A Rising Tide of Polypharmacy

The study revealed that the prevalence of CNS-active polypharmacy has steadily increased in the US, particularly among older adults. The use of antiepileptics, specifically gabapentin, has risen significantly, raising concerns about potential adverse effects and interactions. This increase in polypharmacy raises questions about appropriate prescribing practices and the need for careful monitoring of patients receiving multiple CNS-active medications.

Navigating the Risks and Benefits

The study highlights the need for cautious prescribing of CNS-active medications, particularly in older adults. Like a desert traveler, navigating through a maze of dunes, physicians must carefully consider the potential risks and benefits of polypharmacy and strive to optimize medication regimens to ensure patient safety and efficacy. Regular monitoring and communication between patients and healthcare professionals are essential for safe and effective medication management.

Dr. Camel's Conclusion

This study offers a sobering reminder of the growing trend of CNS-active polypharmacy in the US. It emphasizes the importance of responsible prescribing and the need for close monitoring of patients receiving multiple medications. As the desert landscape of polypharmacy becomes more complex, careful navigation and vigilance are essential to ensure patient well-being.

Date :
  1. Date Completed 2023-09-25
  2. Date Revised 2023-12-13
Further Info :

Pubmed ID

37695395

DOI: Digital Object Identifier

NIHMS1938240

Related Literature

Article Analysis
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.